IN2015DN01688A - - Google Patents

Info

Publication number
IN2015DN01688A
IN2015DN01688A IN1688DEN2015A IN2015DN01688A IN 2015DN01688 A IN2015DN01688 A IN 2015DN01688A IN 1688DEN2015 A IN1688DEN2015 A IN 1688DEN2015A IN 2015DN01688 A IN2015DN01688 A IN 2015DN01688A
Authority
IN
India
Prior art keywords
prepare
inhibiting properties
synthetic
integrase inhibiting
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Dominika Pcion
Carrie Tomasi
Mark Charles Whitcomb
Eric D Dowdy
Wenyi Fu
Patricia Macleod
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of IN2015DN01688A publication Critical patent/IN2015DN01688A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/12Preparation of carboxylic acid esters from asymmetrical anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
IN1688DEN2015 2012-08-03 2013-08-01 IN2015DN01688A (en))

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261679475P 2012-08-03 2012-08-03
PCT/US2013/053295 WO2014022707A1 (en) 2012-08-03 2013-08-01 Process and intermediates for preparing integrase inhibitors

Publications (1)

Publication Number Publication Date
IN2015DN01688A true IN2015DN01688A (en)) 2015-07-03

Family

ID=48980354

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1688DEN2015 IN2015DN01688A (en)) 2012-08-03 2013-08-01

Country Status (17)

Country Link
US (1) US8877931B2 (en))
EP (1) EP2880017B1 (en))
JP (1) JP6147856B2 (en))
KR (1) KR20150040340A (en))
CN (1) CN104520275B (en))
AU (1) AU2013296289B2 (en))
BR (1) BR112015002275A2 (en))
CA (1) CA2878699C (en))
EA (1) EA026089B1 (en))
ES (1) ES2608860T3 (en))
IL (1) IL236618A (en))
IN (1) IN2015DN01688A (en))
MX (1) MX337094B (en))
NZ (1) NZ630199A (en))
PT (1) PT2880017T (en))
SG (1) SG11201500812QA (en))
WO (1) WO2014022707A1 (en))

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030003B1 (ru) 2012-12-21 2018-06-29 Джилид Сайэнс, Инк. Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции
HRP20171808T1 (hr) 2013-07-12 2018-01-26 Gilead Sciences, Inc. Spojevi policikličkog karbamoilpiridona i njihova uporaba za liječenje hiv infekcija
NO2865735T3 (en)) 2013-07-12 2018-07-21
NO2717902T3 (en)) 2014-06-20 2018-06-23
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI738321B (zh) 2014-12-23 2021-09-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
SI3277691T1 (sl) 2015-04-02 2019-04-30 Gilead Sciences, Inc. Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba
US20220332732A1 (en) * 2019-09-24 2022-10-20 Asymchem Laboratories (Tianjin) Co., Ltd. Continuous preparation method for benzylzinc halide and derivative thereof
CN112661698A (zh) * 2021-01-14 2021-04-16 浙江海森药业股份有限公司 一种艾维雷韦的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904108D0 (sv) * 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
DK1343766T3 (da) 2000-12-14 2005-10-31 Procter & Gamble Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner
TW200300349A (en) 2001-11-19 2003-06-01 Sankyo Co A 4-oxoqinoline derivative
WO2003101916A1 (fr) 2002-05-31 2003-12-11 Banyu Pharmaceutical Co., Ltd. Procede d'introduction de substituants par une reaction d'echange halogene-metal
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
TW200409759A (en) 2002-09-25 2004-06-16 Wyeth Corp Substituted 4-(indazol-3-yl)phenols
TWI248928B (en) 2002-11-20 2006-02-11 Japan Tobacco Inc 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
EP1582523A1 (en) 2004-04-02 2005-10-05 Ludwig-Maximilians-Universität München Method of preparing organomagnesium compounds
WO2005113509A1 (en) 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US8633219B2 (en) 2004-05-21 2014-01-21 Japan Tobacco Inc. Combination therapy
WO2007063869A1 (ja) 2005-11-30 2007-06-07 Japan Tobacco Inc. 高純度キノロン化合物の製造方法
US20090233964A1 (en) 2005-12-30 2009-09-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
EA017861B9 (ru) 2006-03-06 2014-05-30 Джапан Тобакко Инк. Способ получения 4-оксохинолинового соединения
IN2014CN00532A (en)) 2006-03-06 2015-04-03 Japan Tobacco Inc
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
SG10201501782UA (en) 2006-09-12 2015-05-28 Gilead Sciences Inc Process and intermediates for preparing integrase inhibitors
CA2691736A1 (en) 2007-06-29 2009-01-08 Gilead Sciences, Inc. Combination of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and lopinavir for the treatment of a viral infection in a human
CN103480000A (zh) 2007-06-29 2014-01-01 吉里德科学公司 治疗用组合物和方法
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa

Also Published As

Publication number Publication date
US20140039194A1 (en) 2014-02-06
EP2880017B1 (en) 2016-10-05
JP6147856B2 (ja) 2017-06-14
IL236618A (en) 2017-04-30
EA201590018A1 (ru) 2015-05-29
MX2015001506A (es) 2015-04-08
AU2013296289B2 (en) 2017-10-05
AU2013296289A1 (en) 2015-02-19
US8877931B2 (en) 2014-11-04
ES2608860T3 (es) 2017-04-17
EP2880017A1 (en) 2015-06-10
HK1209415A1 (en) 2016-04-01
IL236618A0 (en) 2015-02-26
CA2878699C (en) 2018-09-11
JP2015524822A (ja) 2015-08-27
PT2880017T (pt) 2016-12-14
KR20150040340A (ko) 2015-04-14
EA026089B1 (ru) 2017-02-28
SG11201500812QA (en) 2015-04-29
CA2878699A1 (en) 2014-02-06
CN104520275B (zh) 2016-11-02
WO2014022707A1 (en) 2014-02-06
NZ630199A (en) 2016-12-23
HK1209748A1 (en) 2016-04-08
CN104520275A (zh) 2015-04-15
MX337094B (es) 2016-02-10
BR112015002275A2 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
IN2015DN00127A (en))
IN2015DN01688A (en))
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
PH12014502132A1 (en) Anti-lgr5 antibodies and immunoconjugates
PL2986726T3 (pl) Nowe kompozycje szczepów bacillus
MX2017008442A (es) Uso de picolinamidas como fungicidas.
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
MX354303B (es) Anticuerpos de anti-biotina y metodos de uso.
IN2013MU00848A (en))
IN2014DN09450A (en))
IN2013DE00266A (en))
IN2014DN11078A (en))
SG10201900598TA (en) Factor viii formulation
AU2015311730A8 (en) CaMKII inhibitors and uses thereof
IN2014DN06738A (en))
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
IN2014DN07191A (en))
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
UA80618U (en) Use of n-steroylethanolamine as radiomodifier